Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes-Reference-Cited by-同舟云学术

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes

Published:2012-11-27 Issue:11 Volume:7 Page:e49345
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hecht Randy,Li Yue-Sheng,Sun Jeonghoon,Belouski Ed,Hall Michael,Hager Todd,Yie Junming,Wang Wei,Winters Dwight,Smith Stephen,Spahr Chris,Tam Lei-Ting,Shen Zhongnan,Stanislaus Shanaka,Chinookoswong Narumol,Lau Yvonne,Sickmier Allen,Michaels Mark Leo,Boone Thomas,Véniant Murielle M.,Xu Jing

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Hormone-like fibroblast growth factors and metabolic regulation;YC Long;Biochim Biophys Acta,2011

2. FGF-21 as a novel metabolic regulator;A Kharitonenkov;J Clin Invest,2005

3. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21;A Kharitonenkov;Endocrinology,2007

4. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models–association with liver and adipose tissue effects;J Xu;Am J Physiol Endocrinol Metab,2009

5. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice;J Xu;Diabetes,2009

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-aided engineering of stabilized fibroblast growth factor 21;Computational and Structural Biotechnology Journal;2024-12

2. Enhanced bioactivity and stability of a long-acting FGF21: A novel variant for the treatment of NASH;Biochimie;2024-10

3. Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog;Journal of Medicinal Chemistry;2024-07-16

4. Double promoter and tandem gene strategy for efficiently expressing recombinant FGF21;Microbial Cell Factories;2024-06-12

5. Current status and future perspectives of FGF21 analogues in clinical trials;Trends in Endocrinology & Metabolism;2024-05